YM-201636 is a potent and selective inhibitor of the PI3K enzyme, primarily used in research settings to study its effects on cellular processes, particularly in the context of cancer and other diseases. It targets the PI3K signaling pathway, which is involved in cell growth, proliferation, and survival, making it a valuable tool for understanding the mechanisms of abnormal cell behavior. Researchers utilize this compound to explore potential therapeutic applications, especially in inhibiting cancer cell growth. Additionally, YM-201636 is employed in pharmacological studies to assess its efficacy and safety profile, contributing to the development of novel anti-cancer treatments. Its role in laboratory experiments helps advance knowledge in molecular biology and drug discovery.